HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

aldesleukin (Proleukin)

a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant
Also Known As:
Proleukin; BAY 50-4798; 2-133-Interleukin 2 (human reduced), 125-L-serine-
Networked: 55 relevant articles (4 outcomes, 15 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. McDermott, David F: 3 articles (05/2017 - 08/2009)
2. Ernstoff, Marc S: 3 articles (02/2015 - 06/2007)
3. Bond, Simon: 2 articles (01/2018 - 10/2016)
4. Cooper, Zachary A: 2 articles (01/2018 - 01/2015)
5. Reuben, Alexandre: 2 articles (01/2018 - 01/2015)
6. Wargo, Jennifer A: 2 articles (01/2018 - 01/2015)
7. Cheng, Su-Chun: 2 articles (05/2017 - 02/2015)
8. Mier, James W: 2 articles (05/2017 - 02/2015)
9. Panka, David J: 2 articles (05/2017 - 02/2015)
10. Signoretti, Sabina: 2 articles (05/2017 - 02/2015)

Related Diseases

1. Renal Cell Carcinoma (Grawitz Tumor)
2. Neoplasms (Cancer)
3. HIV Infections (HIV Infection)
4. Ovarian Neoplasms (Ovarian Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Interleukin-2 (IL2)
2. Cytokines
3. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
4. chiron
5. Gemcitabine
6. Ipilimumab
7. Hormones (Hormone)
8. Fluorouracil (Carac)
9. Acids
10. Vaccine Adjuvants

Related Therapies and Procedures

1. Highly Active Antiretroviral Therapy (HAART)
2. Therapeutics
3. Nephrectomy
4. Combination Drug Therapy (Combination Chemotherapy)
5. Immunotherapy